In gastric carcinomas, alterations at the FHIT locus or reduced expressions of Fhit have been associated with gastric tumour progression and poor survival of cancer patients (Baffa et al, 1998; Capuzzi et al, 2000). The gene discussed is FHIT; the disease is gastric neoplasm.